An international team with the participation of scientists from the Pomeranian Medical University in Szczecin (PUM) will develop a technology for the early detection of pancreatic cancer in people at high risk. Polish scientists will coordinate epigenetic research conducted within the consortium.

An international team of scientists is carrying out the ‘IMAgene’ project, which is innovative by developing, calibrating and testing a comprehensive cancer risk prediction algorithm, in particular pancreatic cancer, in asymptomatic high-risk patients. The algorithm will integrate clinical, environmental, omic and epigenetic data.

The consortium with the participation of scientists from Poland, Italy, Spain, Romania and France will receive funding from the European Commission under the ERA PerMed program.

Pancreatic cancer is an extremely dangerous disease. It has the lowest survival rate of all cancers in Europe, and patients’ relatives are at least twice as likely to suffer from the disease.

More: https://www.pum.edu.pl/aktualnosci/ogloszenia/pracownia_pum_czci_midzynarodowego_konsorcjum_imagene

jsz